LANXESS donates one million liters of disinfectant solution
- Delivery to 13 severely affected countries
- Disinfectant Rely+On Virkon effective against coronavirus
“We want to help contain the global spread of the coronavirus. With our disinfectant Rely+On Virkon we can effectively contribute to this cause,” said Anno Borkowsky, member of the Board of Management of LANXESS. “Many people, such as hospital employees, are currently risking their own health to save the lives of others. With our donation we also want to protect them.”
The product donation is being given to institutions in 13 countries. In Europe, the product is delivered to Germany, France, Italy, Great Britain, Spain and Poland, in Asia to India, Thailand, Malaysia and Singapore. On the American continent, the donation is being given to recipients in the United States, Brazil and Mexico. “When selecting the countries, we paid attention to where the demand is particularly high and where our product is registered,” explained Anno Borkowsky.
In February, LANXESS had already donated one metric ton of Rely+On Virkon to hospitals in Wuhan, China.
Rely+On Virkon inactivates coronavirus quickly
Independent tests have proven that Rely+On Virkon inactivates a closely related surrogate of the currently spreading coronavirus strain. From these tests it can be concluded that Rely+On Virkon is also effective against SARS-CoV-2.
Rely+On Virkon is diluted for application and sprayed on hard surfaces and equipment. It can therefore help to reduce the risk of contamination via surfaces, door handles, tables or chairs during disinfection measures in hospitals, but also at public transport terminals, airports, shopping malls, etc.
For further information on Rely+On Virkon visit coronavirus.lanxess.com.
Forward-Looking Statements
This company release contains certain forward-looking statements, including assumptions, opinions, expectations and views of the company or cited from third party sources. Various known and unknown risks, uncertainties and other factors could cause the actual results, financial position, development or performance of LANXESS AG to differ materially from the estimations expressed or implied herein. LANXESS AG does not guarantee that the assumptions underlying such forward-looking statements are free from errors, nor does it accept any responsibility for the future accuracy of the opinions expressed in this presentation or the actual occurrence of the forecast developments. No representation or warranty (expressed or implied) is made as to, and no reliance should be placed on, any information, estimates, targets and opinions contained herein, and no liability whatsoever is accepted as to any errors, omissions or misstatements contained herein, and accordingly, no representative of LANXESS AG or any of its affiliated companies or any of such person's officers, directors or employees accepts any liability whatsoever arising directly or indirectly from the use of this document.
